Financials data is unavailable for this security.
View more
Year on year ReproCell Inc had revenues fall -17.83% from 2.95bn to 2.43bn, though the company grew net income from a loss of 305.31m to a smaller loss of 31.41m.
Gross margin | 48.99% |
---|---|
Net profit margin | -7.18% |
Operating margin | -18.53% |
Return on assets | -2.03% |
---|---|
Return on equity | -2.21% |
Return on investment | -2.20% |
More ▼
Cash flow in JPYView more
In 2024, ReproCell Inc increased its cash reserves by 53.51%, or 1.02bn. Cash Flow from Financing totalled 544.05m or 22.42% of revenues. In addition the company used 11.45m for operations while cash from investing totalled 404.42m.
Cash flow per share | -1.57 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 93.57 |
---|---|
Tangible book value per share | 93.31 |
More ▼
Balance sheet in JPYView more
Current ratio | 10.42 |
---|---|
Quick ratio | 9.99 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼